<SEC-DOCUMENT>0001104659-16-132775.txt : 20160715
<SEC-HEADER>0001104659-16-132775.hdr.sgml : 20160715
<ACCEPTANCE-DATETIME>20160715114756
ACCESSION NUMBER:		0001104659-16-132775
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20160713
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160715
DATE AS OF CHANGE:		20160715

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DUPONT E I DE NEMOURS & CO
		CENTRAL INDEX KEY:			0000030554
		STANDARD INDUSTRIAL CLASSIFICATION:	PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) [2820]
		IRS NUMBER:				510014090
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00815
		FILM NUMBER:		161769076

	BUSINESS ADDRESS:	
		STREET 1:		974 CENTRE ROAD
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19805
		BUSINESS PHONE:		3027741000

	MAIL ADDRESS:	
		STREET 1:		974 CENTRE ROAD
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19805
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a16-14993_18k.htm
<DESCRIPTION>8-K
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">WASHINGTON, D.C. 20549</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">PURSUANT TO SECTION&nbsp;13 OR 15(d)&nbsp;OF</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">THE SECURITIES EXCHANGE ACT OF 1934</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of Earliest Event Reported): <b>July&nbsp;15, 2016 (July&nbsp;13, 2016)</b></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">E. I. du Pont de Nemours and Company</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact Name of Registrant as Specified in Its Charter)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1-815</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">51-0014090</font></b></p>    </td>   </tr>
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or Other   Jurisdiction</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer</font></p>    </td>   </tr>
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Of Incorporation)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">File Number)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Identification No.)</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">974 Centre Road</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Wilmington, Delaware 19805</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registrant&#146;s telephone number, including area code:&nbsp;&nbsp; <b>(302) 774-1000</b></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c))</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\16-14993-1\task8021519\14993-1-ba.htm',USER='107541',CD='Jul 15 16:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 7.01</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Regulation FD Disclosure</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On July&nbsp;13, 2016, E. I. du Pont de Nemours and Company (the &#147;Company&#148;) received the letter attached hereto as Exhibit&nbsp;99.1 from Action Network Fund (the &#147;ANF Letter&#148;). The ANF Letter references various pending and potential litigation and investigatory matters to which the Company is now, or may become, a party, including the multi-district litigation (MDL) related to personal injury cases associated with exposure to PFOA (the &#147;PFOA MDL&#148;). The ANF Letter was not prepared by or with any input from the Company. Except as expressly set forth herein, the Company is neither attesting to nor expressing any view regarding the accuracy or completeness of, and may have disagreements with, the information, positions, views and characterizations in the ANF Letter, including without limitation certain of the estimates regarding the number of potential claims or proceedings, potential dollar-value of exposure, future developments regarding the matters and parties and the characterization of the enforceability of DuPont&#146;s indemnification claims against The Chemours Company. The Company takes no responsibility for the content of the ANF Letter. The Company is furnishing the ANF Letter herewith solely to inform the Company&#146;s stockholders of its receipt and content and does not believe it contains any material information not previously disclosed by the Company.&#160; With respect to the matters referenced in the ANF Letter, the Company directs stockholders to information furnished or filed by the Company with the U.S. Securities and Exchange Commission (the &#147;Commission&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contrary to any other assertions made in the ANF Letter, with respect to the matters referenced in the ANF Letter, including the PFOA MDL, the Company has, through information filed and furnished with the Commission prior to the date of this report, disclosed all information required to be disclosed by it under the United States federal securities laws regarding such matters through July&nbsp;14, 2016.&#160; In this regard, the Company refers stockholders in particular to the relevant disclosures in the Company&#146;s Annual Report on Form&nbsp;10-K, filed with the Commission on February&nbsp;4, 2016, the Company&#146;s Quarterly Report on Form&nbsp;10-Q, filed with the Commission on April&nbsp;26, 2016, and its Current Report on Form&nbsp;8-K, furnished to the Commission on July&nbsp;8, 2016.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The information set forth in this Current Report on Form&nbsp;8-K is being furnished pursuant to Item 7.01, and such information shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities under that Section. Furthermore, such information shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Financial Statements and Exhibits.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit<br>   Number</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="87%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:87.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description&nbsp;of&nbsp;Exhibit</font></b></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Letter, dated   July&nbsp;13, 2016, from Action Network Fund to E. I. du Pont de Nemours and   Company and The Dow Chemical Company.</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_052838_1511"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\107541\16-14993-1\task8021519\14993-1-ba.htm',USER='107541',CD='Jul 15 16:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURE</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="54%" valign="top" style="padding:0in 0in 0in 0in;width:54.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.6%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">E. I. DU PONT DE   NEMOURS AND COMPANY</font></p>    </td>   </tr>
<tr>
<td width="54%" valign="top" style="padding:0in 0in 0in 0in;width:54.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.6%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant)</font></p>    </td>   </tr>
<tr>
<td width="54%" valign="top" style="padding:0in 0in 0in 0in;width:54.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="54%" valign="top" style="padding:0in 0in 0in 0in;width:54.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="54%" valign="top" style="padding:0in 0in 0in 0in;width:54.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.6%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Jeanmarie F.   Desmond</font></p>    </td>   </tr>
<tr>
<td width="54%" valign="top" style="padding:0in 0in 0in 0in;width:54.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.6%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jeanmarie F.   Desmond</font></p>    </td>   </tr>
<tr>
<td width="54%" valign="top" style="padding:0in 0in 0in 0in;width:54.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.6%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice President   and Controller</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt 3.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">July&nbsp;15, 2016</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="PB_3_052923_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\107541\16-14993-1\task8021519\14993-1-ba.htm',USER='107541',CD='Jul 15 16:09 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">E. I. DU PONT DE NEMOURS AND COMPANY</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;Index</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit<br>   Number</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="87%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:87.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description&nbsp;of&nbsp;Exhibit</font></b></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Letter, dated   July&nbsp;13, 2016, from Action Network Fund to E. I. du Pont de Nemours and   Company and The Dow Chemical Company.</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="PB_4_052956_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\107541\16-14993-1\task8021519\14993-1-ba.htm',USER='107541',CD='Jul 15 16:09 2016' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a16-14993_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>




  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="191" height="71" src="g149931mmi001.jpg"></font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="151" height="69" src="g149931mmi002.gif"></font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">July&nbsp;13, 2016</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">BY E-MAIL</font></u></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Dow Chemical Company</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">E.I. du Pont de Nemours and   Company</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2030 Dow Center</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">974 Centre Road</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Midland, Michigan 48674</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Wilmington, Delaware 19805</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attn: Board of Directors</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attn: Board of Directors</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Re:</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><u style="font-style:italic;">DowDuPont Merger Proxy</u></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To the Boards of Directors of The Dow Chemical Company and E. I. du Pont de Nemours and Company:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I write on behalf of Keep Your Promises DuPont, a community-based organization dedicated to holding DuPont to the promises made to mid-Ohio Valley communities in connection to contamination with the chemical C-8, also known as PFOA, with respect to a number of inadequate or misleading disclosures in the Companies&#146; joint merger proxy (the &#147;Proxy&#148;), in the hopes that by bringing to the Companies&#146; attention these deficiencies, the Companies will remedy &#151; without the need for shareholders to seek judicial intervention &#151; the disclosure violations in the Proxy and ensure that Dow and DuPont shareholders are provided the requisite disclosures so as to allow them to vote their shares at the Companies&#146; July&nbsp;20, 2016 special meetings.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As you are no doubt aware, under Delaware law, directors have fiduciary duties to shareholders, which include a duty to disclose all facts that are material to the stockholders&#146; consideration of a transaction or a matter. This duty is particularly implicated here, where Dow shareholders are being asked to vote on a merger where they will be inheriting all of DuPont&#146;s liabilities. It is critical that all of those material liabilities be disclosed; to date, they have not been.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In particular, and without limitation, in May&nbsp;2016, the Environmental Protection Agency published a report entitled &#147;Drinking Water Health Advisory for Perfluorooctanoic Acid (PFOA),&#148; in which it issued a lifetime drinking water health advisory for PFOA of 0.07 parts per billion, significantly lowering the prior standard from 0.4 parts per billion. Given the lower standards, there is now an increased and significant possibility that classes from new communities where DuPont operated may assert claims similar to those made by the plaintiffs in the <i>Leach </i>litigation. The number of such cases that are brought could be significant, and if the claimants prevail in a substantial number of cases, could lead to a material increase in DuPont PFOA liability exposure.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109418\16-14993-1\task8021094\14993-1-mm.htm',USER='109418',CD='Jul 15 05:37 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition, as of December&nbsp;31, 2015, DuPont reported that it had been notified of potential liability under CERCLA or similar state laws at 174 sites around the U.S. We further understand that DuPont is aware of potential liability under CERCLA or similar state laws at an additional 19 landfill sites. While The Chemours Company (&#147;Chemours&#148;) has agreed to indemnify DuPont for the costs associated with remediation activities at these sites, as Chemours has stated in its public filings, we are concerned that considerable uncertainty exists with respect to environmental remediation costs and, under adverse changes in circumstances, the potential liability may range up to, or even exceed, approximately $900 million (for the 174 sites identified as of December&nbsp;31, 2015 alone). While Chemours management has stated that it does not believe that any loss, in excess of amounts accrued, related to remediation activities at any individual site will have a material impact on the financial position, liquidity or results of operations of Chemours, there is a material risk that, when aggregated, these remediation expenses will have such a material impact on Chemours and render it unable to meet its indemnification obligations to DuPont. Under such a scenario, DuPont would bear any otherwise indemnifiable liabilities, which could be significant, that Chemours is unable to pay.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Furthermore, since at least March&nbsp;2016, we understand that regulatory authorities in the Netherlands have been investigating claims that PFOA has leached into drinking water in the region surrounding DuPont&#146;s Dordrecht, Netherlands plant. Testing of residents and workers in the Dordrecht region have revealed individuals with blood levels as high as several thousand parts per billion of PFOA, substantially above the national average in the United States. On July&nbsp;11, the Dutch Inspectorate for Social Affairs and Employment announced that the Public Prosecutor is officially investigating the use of hazardous chemicals C-8 and DMAc at DuPont&#146;s facility in Dordrecht, Netherlands. While the prosecutor has not offered substantive details on the investigation, a spokesperson stated that DuPont is suspected of committing &#145;<i>strafbare feiten</i>&#146; or criminal offenses.(1)&nbsp;Similarly, contamination issues have been reported in workers at DuPont&#146;s plant in Shimizu, Japan and in local residents surrounding the company&#146;s plants in Fayetteville, NC and Chambers Works, NJ.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In Dordrecht, over a thousand residents have requested testing. DuPont has stated that it believes it has not engaged in any wrongdoing in these regions. However, it is possible that if these individuals are tested, and the results reveal contamination at the dangerous levels seen in other area residents, we understand there could be substantial liability and exposure for DuPont in any litigation brought based on such testing results. The outcome of any such litigation may be uncertain, but if decided adversely, it could be material to DuPont.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Further, a Columbus jury found DuPont liable for compensatory and punitive damages totaling $5.6M in verdicts on July&nbsp;6 and July&nbsp;8, respectively, representing the largest award for a plaintiff in the 3,500 member <i>Leach </i>class to date. This award alone substantially increases estimates for the final cost of resolving liabilities related to the <i>Leach </i>class. One estimate following the punitive damages verdict on July&nbsp;8 states that the final cost for resolving</font></p>
<p style="margin:0in 0in .0001pt 5.75pt;text-indent:-5.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt 5.75pt;text-indent:-5.75pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="margin:0in 0in .0001pt 5.75pt;text-indent:-5.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)&nbsp; http://www.nu.nl/binnenland/4291583/onderzoekt-gebruik-chemische-stof-c8-bij-dupont.html?redirect=1</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_053456_9444"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\109418\16-14993-1\task8021094\14993-1-mm.htm',USER='109418',CD='Jul 15 05:37 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the approximately 600 cases classified as most serious amongst the 3,500 could range from $1.2 billion to $1.9 billion.(2)&nbsp;It is not clear that DuPont will be indemnified by Chemours for those substantial damages, as it has long claimed. In an 8-K filing shortly after the compensatory verdict on July&nbsp;6, Chemours states, &#147;In the event DuPont claims that it is entitled to indemnification from Chemours as to some or all of the judgment, Chemours retains its defenses to such claims.&#148;(3)&nbsp;This statement calls into question Chemours&#146; indemnification of DuPont for costs related to C-8 liabilities and suggests that the allocation of C-8 liabilities is an unsettled issue, contrary to DuPont&#146;s disclosures to shareholders. If DuPont may bear the burden of C-8 liabilities after all, DuPont and Dow Chemical shareholders must be made aware of this possibility before voting to approve or reject the merger proposal.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">What all of these undisclosed items have in common is that they are substantial, material liabilities that DuPont faces as a result of its decades-long contamination caused by PFOA, and which Dow shareholders stand to inherit in the event the Dow/DuPont merger is consummated. Yet none of those liabilities has been disclosed in the Proxy, in clear derogation of the directors&#146; fiduciary duties to their shareholders.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We expect that by bringing this matter to the attention to the Dow and DuPont boards of directors, the Companies can remedy their defective disclosures immediately, in advance of the Companies&#146; special meetings, and without need for further shareholder action. Given that the special meetings are currently scheduled to take place on July&nbsp;20, 2016, we ask that the Companies supplement the Proxy to address the deficiencies enumerated above &#151; as well as any and all additional disclosures consistent with the directors&#146; fiduciary duties.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please feel free to contact us if you would like to discuss this matter further.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sincerely,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="131" height="98" src="g149931mmi003.gif"></font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mark Fleischman</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Action Network Fund</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="margin:0in 0in .0001pt 5.75pt;text-indent:-5.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)&nbsp; http://www.bloomberg.com/news/articles/2016-07-08/dupont-must-pay-500-000-in-punitive-damages-for-man-s-cancer</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 5.75pt;text-indent:-5.75pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)&nbsp; http://d1lge852tjjqow.cloudfront.net/CIK-0001627223/86205171-49e7-4238-be9e-79aa926a35ee.pdf?noexit=true</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="PB_3_053631_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\109418\16-14993-1\task8021094\14993-1-mm.htm',USER='109418',CD='Jul 15 05:37 2016' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g149931mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149931mmi001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !' +\# 2(  A$! Q$!_\0
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M+%) 580KP>HK1H **** "DI:* "BBB@ HHHH **** "BBB@ JK<VQFNK64,
M('9B/7*E?ZT44 6>U4]1T_[9&ICE:&>,YCE49*^HQW!]*** *TEGJUQ$(I+R
M&%3]Z2&,[R/;)P/UJ:]TQ9]$ET^ B-6C\M2><444 7@,@5E7.BA]<MK^*01J
MC%I(\<.VTJ&^N#110 YK*^BU&YN+26W"7&TD2*21M&.QI#IMW>2K_:5S&T"G
D/D1)M5_]XDG(]N*** -4#  I:** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g149931mmi002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149931mmi002.gif
M1TE&.#=AEP!% '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M0+"!>06"T\)<0$)B P94*&\!P7,+T08@1$=.X3#RYPLXMR@.6MZ""_TBL?^
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M(E9+1]HJU*/S12))H,$-9@$DQLIV4'D,-GG O?=:2<  1:E:S6$0D/<2 )%
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MG?]:UY(6,<1Y-)*,)(15)+9-[0 2XX[96/B(2%S@>"[$DD0(8('@5,-D!&#
M/(('+[00Y4P7($\%_..T U!& I##G0 -8 'BY8AY#VL E<!7%+.XYVT'(-L\
MXO&]9+&-?J>*2%K*$PD(7 9G]N#81)!"IG]88$.F4X$D&O C*\:CA6NK24IX
M5IP*9"D=$:1,DI:5CBX6X 'B*2$\^+@TQKBP8ZZT@#WP$1SRD20=!X@.+&!1
M#2:>Y46+\QCUO//!C*QE(UX*  O$I\0&G(8D17+> EJ #\ ,1Q(,8(%Y!G(
M'-U# ;9Y6_$*8,JS</%R"T +^@AF@'S8J *6^> 9._/_P;P$X  A"U<%XF&
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M*#0OC75/&O_D$P\U-\\19T1!9=ZA(<P! 6>C0%7B)QA2#=QG 14 "X#Q#PW
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M-F$> :B,V]9329*Z0V:.K80F<9=Y*UD_RN0=_9ANE[%5*80+)K>:/68!8U0
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M57'] QP=(0*9B$)2J/$:8+(U+;)CGW>5?^&EO%$5HAC <F7BKMP AX(^ !$
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-NSI+/P;]&Q"B@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g149931mmi003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g149931mmi003.gif
M1TE&.#=A@P!B '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MR$ )=&&.;7 A"]L@AS> H !<S*-=<#[',ZJP@DY8@011L,(*F,!X%W#A&/+
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ME  *D2 "&__@ G)P!5GP"72@ I5P#\B !!Q0"*GP 5VP'"-A#LWA#87P U&
M#=_0!P10 $_P"N#P#530 I& #\00!0S !MQP&4+"1$1R#L/ !T[@"V&  EV0
M!7T !F90!GT !&)@#?;@"DK0!HD@!S30"3XB;@@Q)9UR#8@P!9V0#_/@!Q<@
M 2XP".\@#K< !8; #?"0""9P!-[0#F7!7KIA*J;""F;0!8-0"DW0 C 0";2
M!X^P"U! !:L "Y;@!70P#+BP F]P"N:@*39X$NV0"8M'#2!F30XP!_R #L\0
M!F[ #O(0#5<P!8;P*9TC)#[!(H4@ DG0"I,0 QIP 910"GY@"9/_H 1F( IB
ML <R< ?N  I3$ C$,"@9B! -<0U0P -WP WH\ 8.L  4H G<)@IHP B^D0LF
M@ ;30$+CH9+-$0[+T 0J0 FN  0_< -N4 E#@ F0( (V  5-L (L@ *IL UX
M0 ?N<!$_X7+_P LR, 6CT%]9M !F0!:X0 1F< SAP ]KH **,(_F$&Y5<@[R
MLP>.  MO< ,U4 60  4[P =#P $E\ (-D  \  G/\ =QL N+1237HA"!T0H^
MT 76  U%, $0L *N, [*P =A=0_QD HHP 3 \)K86!\,,4SI0 UT\ FU8 @X
M\ $\\ =K( 5%T 8LH (Q< $8@ $\L AZ_] ")1 )JB +Z)F>MU *S\ -[\ /
M_/ .^0"?\S /^J ,C1 "3V +CG "%@ !1Y )LT )): #;W +DI &.< $G# +
MK0 ,[Q"A\#FA\5F?[E 3^I.A) 08Q&0H&J$H(W$3)P$*9\ "T* -=,  '_ '
MNH &9J (1@ "6+ "')  'J  )B !%7 !+R #,?"C0(H",0 $?6 '=_ '9/ &
M=] '=^ &;C '0F  .E $*Z !&5 !*F "-[ !#T #/, ".\ !'' #)_ "+( $
M?F '<Q &;-JF;O ';( (NX +NI *=FJGNQ +^R /\! VES$.JB21)-$<E* %
M3W ,MO $#J #I?]0#&= ";L@!%>0"5'  1[0 0)   KP !%  B=  J :JN,8
M B3  S&@ YIZ  Q@  ;0I0^   1P A/PG<R2 Q+0 0R0 [.Q  *@ !N@ RJP
M SX0 %>G ,9ZK!+P  :  U1@!F@ !] *K5006M.P#.84,H8R0O1H$U=T C-0
M"IO0!0_0 6>@"V.0!WZP!TP "8U@ PO  %%0"FSP!9I@#.( #^Z0K_H:#^+0
M#\KP#O< #*M@"J.P"@.["KG0""Z0 T3@G43 "OA0"UG@ X'0#]< !@WP!=6P
M#N*P#OT #]A@L"(KLJB0"Z80"Y+ !V$P!RS+LFYP!E>  RL@!%$ !V7_< O'
MX _Z$QA*5Q#"X =T@@I!0  30 2^< A5L =;\ )J\ E1H ,10 2B$ H_X 3^
MH%Y'"3R=D@[!8@Y>ZTL8R U$X '7)P!^H _@@ LO%0ON  U3< %XP \]%C$0
MX[5V:PZW,9G]X ]\V[?^@ [U@ JT@ NST E 8 -'0 6?\ U.ED';NA'8  15
MP G,@ ,>0 !MD QXH -7$ ,)UPDP, $4X 2D( L$P =3DB\? 2IRA70"80]7
MX $)@ $!$ C>TP@^P ?2, ZI\*F:<!M?D2V\.!!.05TUPQS,X1'P@ _K@ [?
M( E#\ ,7$ 2[P ]O,I'NE0U/0 ,_@ W2( @-_U($T( ,0% !#@ #;M (5X
M$) &WJ -:@ %U  J^I0@?@(*,( !&3 !:/ -Y0 *5: &W; /OL $34 +7C&\
M2#E,_Y Q;%$5S3$>#"%-_4 ,K8 &7Y %@K -/// O!+!LW  *8 'RU +5O !
M*? )[) *+""[9A +D; #&: "F^ -F% $J8 .D]2S$34.BI #'H !1- +' L(
M5K +X% +7+"55:2&% %G-2@0^?HI] "H;Q(RY$ /PH (:4 $;U -#+$K0/47
M O$)!N "J: /J>"N1  *[F (/(  &O ) ]@ 'Z %I? +0! $VR .?E*_)4$/
MCK #HI$'P1 /P; '5/\ #>2 "R_  Y%P$2,4$AD2#\X&9_* MR=$$.J M_?@
M"R+@ YR 0@K\4^7@#M:P D4@"O!@"4)P &L #? P#W/P !5@!H! !S5@ $0@
M";Y !T_@"?/!PS-S#L1 !1K@ 3401O?@!CLP"/5P"E^  ")@"CRK=%>1#L,@
M"^<:!UK@ FG) C$@!%2@!H  #/:0*1B1*\$0!EEP"ZH5FS/S%ZF@!BT "L2P
M#T,0 #GP##_27!/@ Y0P!!5@ 3C ",S "#M0!;U 0DI5*ON@"C&0 1# !,%0
M#JX0 RAP"KC) 11 !LMQ$IJG$.DP#:% !RN@!4/0!X< ")S0") P"9V !Y+_
M2P>(P VQYAOFD Y<=02ZL _DD1#B< 8R4 /90 _\< 0,D 3.(#W X 400 2;
M$ 0=@ !6  W2X @-@ 6Y$( M40[10 DUX $"< ;^NPDDL 6YP @ZT $2$ GP
M<+Q*MPZH  02\ )O@ B\( S[< _V  _^L S)< E"  -)@ C=( ],I ]^\ !G
MD U![2[ZH 92J@KB8 Z70 ,C< OV0 [.I -3\ F.P (9@ .D0 _,H 9)D JR
M)A(>0;__0 ]I0  #  %58 O]P ]QP *&0 M?L  =  *S@$&#0DP5\1?J4 _Y
M  I'P )4L O*<"_#))&=T@[K\ QR, -/@ >GD+,P_Y(,4K !C6!#85T#;R *
M_M .R; '1F )^D >M1 $.= (I& $ K !^G</EI '@! -7_V5Y< +*9 !'M %
MA, /XQ +(F $J9 '/A #+, &SA!1Q8T/Y& ,=K %3R (O+ /9V<63[$O^! ,
MB. '6& #;O -1<(+-T P"%$+-S !H/ .OA(-6# &J!!KY? *3Z %J# *4P !
M-A *YH ,?C 'T> =)<$2GP)F?G  'N !?3 *?9H(3> (@8 "1+ %5W Z@-(I
M+ $._E (%% #0R -Z[ :+)(0S.$.Q! +>C "1) (#7$,-H %_9 OUN 'OF!"
MX9 +8  "QD 3[2 -;# #>/^ !B\@ 4;@"^^@#XG !9DP/4L.)/+@"S,P !X@
M [%@2/Q0!E 0"7"P!X=@!'C #I0Y,U=!-K6@!3Y !Y8P#X1!)?GC)^0A#]C
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19J74'"D\G[(&.VRQ\PT( #L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
